Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes

Sean L. Zheng(Imperial College London), Karim Meeran(Imperial College London)
JAMA
April 17, 2018
Cited by 406


Related Papers